Charles Zaloudek, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Charles Zaloudek, MD

Professor, Department of Pathology, UCSF

Phone: (415) 353-1734 (appts)
Box 0102, UCSF
San Francisco, CA 94143-0102

UCSF Profiles | Physician Referral Directory

Cancer Center Membership

Associate Member » Cancer Genetics

Education

University of California, Berkeley, CA, A.B., 1967
Johns Hopkins School of Medicine, Baltimore, MD, M.D., 1971, Medicine
Stanford University, Stanford, CA, Resident, 1971-73, Pathology
Stanford University, Stanford, CA, Fellow, 1973-74, Surgical Pathology


Professional Experience

  • 1974-75
    American Cancer Society Clinical Fellow in Anatomic Pathology, MD Anderson Hospital and Tumor Institute, Univ. Texas System Cancer Center, Houston, TX
  • 1975-77
    Staff Pathologist, DD Eisenhower Army Medical Center, Fort Gordon, GA
  • 1975-77
    Clinical Assistant Professor of Pathology, Medical College of Georgia, Augusta, GA
  • 1977-80
    Staff Pathologist, Dept. Gynecologic and Breast Pathology, George Washington Univ. School of Medicine, Washington, DC
  • 1980-83
    Assistant Professor of Pathology, George Washingon Univ. School of Medicine
  • 1983-86
    Associate Professor of Pathology, George Washington Univ. School of Medicine
  • 1986-92
    Anatomic Pathologist, Director of Cytopathology, Alta Bates Medical Ctr., Berkeley, CA
  • 1989-93
    Associate Clinical Professor of Pathology, University of California San Francisco, CA
  • 1993-present
    Professor of Clinical Pathology, University of California San Francisco, CA

Selected Publications

  1. Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IeM, Kurman RJ. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study. Int J Gynecol Pathol. 2016 Jan; 35(1):48-55.
    View on PubMed
  2. Joseph NM, Solomon DA, Frizzell N, Rabban JT, Zaloudek C, Garg K. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients. Am J Surg Pathol. 2015 Nov; 39(11):1529-39.
    View on PubMed
  3. Rabban JT, Firetag B, Sangoi AR, Post MD, Zaloudek CJ. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex. Am J Surg Pathol. 2015 Aug; 39(8):1015-25.
    View on PubMed
  4. Chapman JS, Asthana S, Cade L, Chang MT, Wang Z, Zaloudek CJ, Ueda S, Collisson EA, Taylor BS. Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course. J Natl Compr Canc Netw. 2015 Jul; 13(7):835-45.
    View on PubMed
  5. Rabban JT, Vohra P, Zaloudek CJ. Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia. Am J Surg Pathol. 2015 Jan; 39(1):35-51.
    View on PubMed
  6. Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol. 2014 Jun; 38(6):729-42.
    View on PubMed
  7. Can NT, Robertson P, Zaloudek CJ, Gill RM. Cervical squamous cell carcinoma metastatic to placenta. Int J Gynecol Pathol. 2013 Sep; 32(5):516-9.
    View on PubMed
  8. Karnezis AN, Aysal A, Zaloudek CJ, Rabban JT. Transitional cell-like morphology in ovarian endometrioid carcinoma: morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma. Am J Surg Pathol. 2013 Jan; 37(1):24-37.
    View on PubMed
  9. Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology. 2013 Jan; 62(1):71-88.
    View on PubMed
  10. Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol. 2012 Feb; 36(2):163-72.
    View on PubMed
  11. Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, Moore DH, Ziegler J. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011 Jul; 21(5):846-51.
    View on PubMed
  12. Rabban JT, Mackey A, Powell CB, Crawford B, Zaloudek CJ, Chen LM. Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation. Gynecol Oncol. 2011 Jun 1; 121(3):466-71.
    View on PubMed
  13. Rabban JT, Karnezis AN, Zaloudek CJ. Junctional epithelial zones of the fallopian tube: cancer hotspots? Int J Gynecol Pathol. 2011 Jan; 30(1):1-3.
    View on PubMed
  14. Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am J Surg Pathol. 2010 Feb; 34(2):137-46.
    View on PubMed
  15. Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009 Dec; 33(12):1878-85.
    View on PubMed
  16. Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009 Aug; 33(8):1125-36.
    View on PubMed
  17. Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations. Am J Surg Pathol. 2009 Jan; 33(1):111-9.
    View on PubMed
  18. Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol. 2009 Jan; 28(1):41-8.
    View on PubMed
  19. Hosfield EM, Rabban JT, Chen LM, Zaloudek CJ. Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int J Gynecol Pathol. 2008 Oct; 27(4):465-74.
    View on PubMed
  20. Rabban JT, Zaloudek CJ. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis. Pathology. 2007 Feb; 39(1):125-33.
    View on PubMed

Go to UCSF Profiles, powered by CTSI